BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30850363)

  • 1. Correlation of
    Wazir U; Orakzai MMAW; Martin TA; Jiang WG; Mokbel K
    Cancer Genomics Proteomics; 2019; 16(2):121-127. PubMed ID: 30850363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stratification Using hTERT and Stem Cell Markers Confers a Good Prognosis in Invasive Breast Cancer.
    Wazir U; Tayeh S; Orakzai MAW; Martin TA; Jiang WG; Mokbel K
    Cancer Genomics Proteomics; 2020; 17(2):169-174. PubMed ID: 32108039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues.
    Hines WC; Fajardo AM; Joste NE; Bisoffi M; Griffith JK
    Mol Cancer Res; 2005 Sep; 3(9):503-9. PubMed ID: 16179497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.
    Silva J; García JM; Peña C; García V; Domínguez G; Suárez D; Camacho FI; Espinosa R; Provencio M; España P; Bonilla F
    Clin Cancer Res; 2006 Dec; 12(23):6929-36. PubMed ID: 17145810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of telomerase reverse transcriptase mRNA and its quantitative analysis in human endometrial cancer.
    Oshita T; Nagai N; Ohama K
    Int J Oncol; 2000 Dec; 17(6):1225-30. PubMed ID: 11078809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
    Alberti L; Losi L; Leyvraz S; Benhattar J
    PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ets2 transcription factor, telomerase activity and breast cancer.
    Dwyer JM; Liu JP
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):83-7. PubMed ID: 19566835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance.
    Teichroeb JH; Kim J; Betts DH
    RNA Biol; 2016 Aug; 13(8):707-19. PubMed ID: 26786236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer.
    Wu XQ; Huang C; He X; Tian YY; Zhou DX; He Y; Liu XH; Li J
    Cell Signal; 2013 Dec; 25(12):2462-8. PubMed ID: 23993966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEBP factors regulate telomerase reverse transcriptase promoter activity in whey acidic protein-T mice during mammary carcinogenesis.
    Kumar M; Witt B; Knippschild U; Koch S; Meena JK; Heinlein C; Weise JM; Krepulat F; Kuchenbauer F; Iben S; Rudolph KL; Deppert W; Günes C
    Int J Cancer; 2013 May; 132(9):2032-43. PubMed ID: 23023397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-630 inhibits breast cancer progression by directly targeting BMI1.
    Gong XF; Yu AL; Tang J; Wang CL; He JR; Chen GQ; Zhao Q; He M; Zhou CX
    Exp Cell Res; 2018 Jan; 362(2):378-385. PubMed ID: 29208462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of primary breast cancer cells with enhanced pluripotency and stem cell activity to sex hormonal stimulation and suppression.
    Nasr M; Farghaly M; Elsaba T; El-Mokhtar M; Radwan R; Elsabahy M; Abdelkareem A; Fakhry H; Mousa N
    Int J Biochem Cell Biol; 2018 Dec; 105():84-93. PubMed ID: 30359767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations.
    Cevik D; Yildiz G; Ozturk M
    World J Gastroenterol; 2015 Jan; 21(1):311-7. PubMed ID: 25574106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance.
    Wei CY; Tan QX; Zhu X; Qin QH; Zhu FB; Mo QG; Yang WP
    Int J Clin Exp Pathol; 2015; 8(11):14619-29. PubMed ID: 26823785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCG2 is a potential marker of tumor-initiating cells in breast cancer.
    Sicchieri RD; da Silveira WA; Mandarano LR; de Oliveira TM; Carrara HH; Muglia VF; de Andrade JM; Tiezzi DG
    Tumour Biol; 2015 Dec; 36(12):9233-43. PubMed ID: 26091795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals.
    Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G
    Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Liu L; Liu C; Fotouhi O; Fan Y; Wang K; Xia C; Shi B; Zhang G; Wang K; Kong F; Larsson C; Hu S; Xu D
    Oncologist; 2017 Oct; 22(10):1178-1188. PubMed ID: 28754720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence.
    Patel PL; Suram A; Mirani N; Bischof O; Herbig U
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E5024-33. PubMed ID: 27503890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
    Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
    Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.